97161 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons; Interleukins [IL] IL-2
PHARMACEUTICAL COMPOSITION CONTAINING FUSION PROTEIN
#2ANTI-IL-2 ANTIBODY COMBINATIONS AND METHODS OF USE THEREOF
#3ALL-IN-ONE AGONISTIC ANTIBODIES
#4MASKED IL-2 CYTOKINES AND METHODS OF USE THEREOF
#5METHODS OF TREATING THE EFFECTS OF CYTOKINE STORMS
#6USE of Antibody Mutation FOR Therapeutic Antibody Drug
#7HUMANIZED CC CHEMOKINE RECEPTOR 4 (CCR4) ANTIBODIES AND METHODS OF USE THEREOF
#8NOVEL CYTOKINE-BASED THERAPIES AND METHODS
#9Interleukin-2 Mutant and Application Thereof
#10MULTIFUNCTIONAL BISPECIFIC FUSION POLYPEPTIDE
#11ENGINEERED ANTI-IL-2 ANTIBODIES
#12METHODS FOR IN VIVO EXPANSION OF CD8+ T CELLS AND PREVENTION OR TREATMENT OF GVHD
#13Anti-SIRPa Antibodies and Methods of Use Thereof
#14IL-2 TRAP MOLECULES
#15COMPANION METHODS AND KITS FOR IL-2-BASED THERAPIES AND MESENCHYMAL STEM CELL-BASED THERAPIES
#16MASKED IL-2 CYTOKINES AND METHODS OF USE THEREOF
#17VHH MASKED CYTOKINES AND METHODS OF USE THEREOF
#18COMPOSITIONS AND METHODS FOR DELIVERY OF IL-2 AND ANTI-IL-2 FOR TREATMENT OF RHEUMATOID ARTHRITIS
#19INTERLEUKIN-2 AGENTS AND USES THEREOF
#20COMBINATION THERAPY WITH ARENAVIRUS PARTICLES AND IMMUNE CHECKPOINT MODULATORS OR CYTOKINES
#21Linker Polypeptides
#22MULTIFUNCTIONAL MOLECULES BINDING TO TCR AND USES THEREOF
#23COMPOSITIONS OF PROTEIN COMPLEXES AND METHODS OF USE THEREOF
#24ANTI-NECTIN4 ANTIBODIES AND MULTI-SPECIFIC PROTEIN COMPLEXES COMPRISING SUCH
#25IMMUNE-STIMULATING HUMANIZED MONOCLONAL ANTIBODIES AGAINST HUMAN INTERLEUKIN-2, AND FUSION PROTEINS THEREOF
#26IMMUNOCONJUGATE MOLECULES AND RELATED METHODS AND COMPOSITIONS THEREOF
#27INTERLEUKIN-2 MUTEINS FOR THE EXPANSION OF T-REGULATORY CELLS
#28MODULATING THE EFFECTS OF GAMMA-C-CYTOKINE SIGNALING FOR THE TREATMENT OF ALOPECIA AND ALOPECIA ASSOCIATED DISORDERS
#29Anti-SIRPα antibodies and methods of use thereof
#30METHODS OF USE OF ANTI-IL-2 ANTIBODIES
#31METHODS OF USE OF ANTI-IL-2 ANTIBODIES
#32METHODS TO GLYCOENGINEER PROTEINS
#33Interleukin-2 agents and uses thereof
#34POLYPEPTIDES WITH ALTERED BINDING TO NEONATAL FC RECEPTOR (FCRN) AND METHODS OF USE
#35CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELLS
#36MODIFIED ANTI-TSLP ANTIBODIES
#37IMMUNE-STIMULATING IL-2 FUSION PROTEINS
#38ENGINEERED CLEAVABLE CARRIERS AND METHODS OF USE THEREOF
#39HUMANIZED CC CHEMOKINE RECEPTOR 4 (CCR4) ANTIBODIES AND METHODS OF USE THEREOF
#40LDL RECEPTOR-DIRECTED BISPECIFIC BINDING AGENT-LIGAND FUSIONS FOR THE DEGRADATION OF TARGET PROTEINS
#41Engineered anti-IL-2 antibodies
#42PREVENTION AND TREATMENT OF GRAFT-VERSUS-HOST DISEASE (GVHD)
#43Compositions of protein complexes and methods of use thereof
#44Antigen Presenting Polypeptide Complexes and Methods of Use Thereof
#45USE OF INSULIN-LIKE GROWTH FACTORS WITH GAMMA-CHAIN CYTOKINES TO INDUCE HOMEOSTATIC PROLIFERATION OF LYMPHOCYTES
#46LUNG CANCER COMBINATION THERAPY WITH IL-2 CONJUGATES AND AN ANTI-PD-1 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF
#47ANTI-IL-2 ANTIBODIES AND COMPOSITIONS AND USES THEREOF
#48A CD25-BIASED ANTI-IL-2 ANTIBODY
#49MULTISPECIFIC ANTIBODY MOLECULES COMPRISINGLAMBDA AND KAPPA LIGHT CHAINS
#50IMPLANTABLE SCAFFOLDS AND USES THEREOF FOR IMMUNOTHERAPY AND OTHER USES
#51Engineered anti-IL-2 antibodies
#52Anti-IL-2 Antibody, and Antigen-Binding Fragment Thereof and Medical Use Thereof
#53Engineered anti-il-2 antibodies
#54FORMULATIONS OF HUMAN ANTI-TSLP ANTIBODIES AND METHODS OF USING THE SAME
#55LIGAND-BINDING FUSION PROTEINS
#56Method of Treating Psoriasis in Pediatric Subjects with Anti-IL12/IL23 Antibody
#57IMPLANTABLE SCAFFOLDS AND USES THEREOF FOR IMMUNOTHERAPY AND OTHER USES
#58METHODS AND MATERIALS FOR TARGETED EXPANSION OF IMMUNE EFFECTOR CELLS
#59METHODS AND DEVICES FOR THE PRODUCTION AND DELIVERY OF BENEFICIAL FACTORS FROM STEM CELLS
#60METHODS OF HIGH-THROUGHPUT IDENTIFICATION OF T CELL EPITOPES BY CAPTURING CYTOKINES ON THE SURFACE OF ANTIGEN-PRESENTING CELLS
#61IL-2 COMPOSITIONS AND METHODS OF USE THEREOF
#62Anti-SIRPa antibodies and methods of use thereof
#63METHODS AND MATERIALS FOR TARGETED EXPANSION OF REGULATORY T CELLS
#64Compositions of protein complexes and methods of use thereof
#65INHIBITION OF KIDNEY DISEASE RELAPSE BY TARGETED CYTOKINE DEPLETION
#66DUAL BINDING MOIETY
#67Immune-stimulating humanized monoclonal antibodies against human interleukin-2, and fusion proteins thereof
#68IMMUNE-STIMULATING MONOCLONAL ANTIBODIES AGAINST HUMAN INTERLEUKIN-2
#69Antibodies that bind interleukin-2 and uses thereof
#70Interleukin-2 muteins for the expansion of T-regulatory cells
#71Targeted immunotolerance
#72Anti-IL-2 antibodies and compositions and uses thereof
#73Interleukin-2 agents and uses thereof
#74Humanized CC chemokine receptor 4 (CCR4) antibodies and methods of use thereof
#75Modulating the effects of gamma-c-cytokine signaling for the treatment of alopecia and alopecia associated disorders
#76Method of Treating Psoriasis in Pediatric Subjects with Anti-IL12/IL23 Antibody
#77PEPTIDES FOR USE IN TREATMENT AND DIAGNOSIS OF TYPE 1 DIABETES
#78Anti-human interleukin-2 antibodies and uses thereof
#79METHODS FOR IN VIVO EXPANSION OF CD8+ T CELLS AND PREVENTION OR TREATMENT OF GVHD
#80METHOD FOR DIAGNOSING AND TREATING ATTENTION DEFICIT HYPERACTIVITY DISORDER
#81Interleukin-2 muteins for the expansion of T-regulatory cells
#82Compositions of polymeric nanowires and methods of making and using thereof
#83IMMUNOCYTOKINE COMBINATION THERAPY
#84Anti-SIRPA antibodies and methods of use thereof
#85PNEUMOCOCCAL INHIBITORY FACTOR COMPOSITIONS AND METHODS OF USE THEREOF
#86Multispecific antibody molecules comprising lambda and kappa light chains
#87ENGINEERED HETERODIMERIC PROTEIN DOMAINS
#88Anti-IL-2 antibodies and compositions and uses thereof
#89METHODS FOR THE DIAGNOSTIC OF AN AUTOIMMUNE DISEASE
#90Immune-stimulating humanized monoclonal antibodies against human interleukin-2, and fusion proteins thereof
#91COMBINATION THERAPY COMPRISING A SUPERAGONISTIC ANTIBODY AGAINST INTERLEUKIN-2 AND A CHECKPOINT BLOCKADE AGENT
#92Targeted immunotolerance
#93Method for enrichment and expansion of virus antigen-specific T cells
#94IL2Rbeta/common gamma chain antibodies
#95Methods and devices for the production and delivery of beneficial factors from adipose-derived stem cells
#96Treatment with an IL-2 based therapy
#97Antibodies that bind interleukin-2 and uses thereof
#98Hypotaurine, GABA, Beta-Alanine, and Choline for Control of Waste Byproduct Accumulation in Mammalian Cell Culture Process
#99Humanized CC chemokine receptor 4 (CCR4) antibodies and methods of use thereof
#100INHIBITION OF IL-2 PRODUCTION
#101Immune-stimulating monoclonal antibodies against human interleukin-2
#102CANCER-TARGETED IL-12 IMMUNOTHERAPY
#103Anti-IL-2 antibodies and compositions and uses thereof
#104IL-2 peptide derivatives, and uses thereof for the diagnosis and treatment of an autoimmune disease
#105METHOD OF TREATING A PATHOLOGICAL SYNDROME
#106Methods and arrays for use in the same
#107Method of site specific activation of an antibody by a protease
#108Engineered heterodimeric protein domains
#109Compositions comprising TL1A-Ig fusion protein for the regulation of T regulatory cells, and methods for their use
#110Method of treating hypertension disorder and a pharmaceutical agent
#111Immunomodulatory methods and systems for treatment and/or prevention of hypertension
#112Stable aqueous pharmaceutical formulations of daclizumab antibodies
#113Method for administering homeopathically potentiated antibodies against mediator of inflammation
#114STABLE LIQUID PHARMACEUTICAL FORMULATION OF IGG ANTIBODIES
#115Methods for Improving Immune Function and Methods for Prevention or Treatment of Disease in a Mammalian Subject
#116COMBINATION THERAPY TO INHIBIT T CELL EFFECTOR FUNCTION
#117PEPTIDES OF IL-2
#118Method of treating disorders of the cardiovascular system and a pharmaceutical agent
#119Method of treating a pathological syndrome and a pharmaceutical agent
#120Method of treating a disorder or condition of viral etiology
#121Method for administering homeopathically potentized antibody
#122Method for Controlling Immunodominance
#123Anti-IL2 antibodies
#124Method of treating a pathological syndrome and a pharmaceutical agent
#125Method of treating a pathological syndrome and a pharmaceutical agent
#126Method of treating a pathological syndrome and a pharmaceutical agent
#127Method of treating a pathological syndrome and a pharmaceutical agent
#128Method of treating a pathological syndrome and a pharmaceutical agent
#129Polynucleotides encoding modified HIV-1 gp41 membrane polypeptides
#130Immobilization of glycoproteins
#131Engineered heterodimeric protein domains
#132Method of treating a pathological syndrome and a pharmaceutical agent
#133Method of inducing SHC phosphorylation of inducing the SHC/MAPK pathway by administering a peptide of IL-2
#134Immobilization of glycorproteins
#135Method for inducing selected useful activities of IL-2 in a patient with peptides from IL-2
#136Polynucleotide encoding a mutated HIV gp41 polypeptide
#137Immune-stimulating IL-2 fusion proteins
#138Peptides for use in treatment and diagnosis of type 1 diabetes